First Anti-Tumor Drug
NS-1 destroys resistant bacteria and cancer cells, without harming healthy tissue. Backed by independent lab testing.
NS-1 is verified breakthrough. We discovered a turning point.
Antibiotic Activity
NS-1 represents a substance effective against pathogenic bacteria resistant to all known antibiotics, for which there are currently no adequate cures globally.
Our initial goal was to create a super-antibiotic with consistent effectiveness in destroying pathogenic bacteria without the possibility of resistance which has been achieved thanks to the team of scientists involved in the project.
Anti-Tumor Activity
NS-1 destroys tumor cells with an unexpectedly fast and effective mechanism of action.
Discovery of NS-1 antitumor effect occurred spontaneously during research.
The Discovery Path of NS-1
Discovery Phase
Uncovered compound with unique cytoplasmic mechanism.
Proof of Concept
Repeated lab testing confirms effect on resistant strains.
Anti-Tumor Effect
Proven destruction of colon cancer cells without harming healthy tissue.
Intellectual Property
Patent secured for formula and application.
Next Stage
Preparing for preclinical trials and strategic partnerships.
Validated. Proven. Unmatched.
- Lab-verified in independent studies
- Dual-action: antibiotic and anti-tumor
- Legally protected by international patent
Want access to the full scientific dossier?
If you are a qualified investor, contact us for access to our documentation and validation results.
